Abstract
Introduction: Adjuvant hormonal therapy (AHT) lowers recurrence in hormone receptor–positive breast cancer, but evidence comparing its impact on quality of life (QoL) across menopausal status is limited. This study aimed to compare QoL across different AHT regimens in premenopausal and postmenopausal women with breast cancer. Methods: In this cross-sectional study, ...

This publication has 25 references indexed in Scilit: